Ebola Virus Infection
4 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Putative Investigational Therapeutics in the Treatment of Patients With Known Ebola Infection (NCT02363322) | National Institute of Allergy and Infectious Diseases (NIAID) | 2015-03-13 |
| A Phase 1 Study to Evaluate the Safety, Tolerability and Pharmacokinetics of BCX4430 (NCT02319772) | BioCryst Pharmaceuticals | 2014-12-01 |
| Safety, Tolerability and Pharmacokinetic First in Human (FIH) Study for Intravenous (IV) TKM-100802 (NCT02041715) | Arbutus Biopharma Corporation | 2014-01-01 |
| Safety, Tolerability and Pharmacokinetic First in Human (FIH) Study of Intravenous (IV) TKM-100201 Infusion (NCT01518881) | Arbutus Biopharma Corporation | 2012-01-01 |
Track Ebola Virus Infection automatically
Every clearance here is in the API, with alerts when new ones post.